Filters: Author is Björklund, Anders [Clear All Filters]
Li JY, Englund E, Widner H, Rehncrona S, Björklund A, Lindvall O, et al. Characterization of Lewy body pathology in 12- and 16-year-old intrastriatal mesencephalic grafts surviving in a patient with Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society. 2010.
Grealish S, Mattsson B, Draxler P, Björklund A. Characterisation of behavioural and neurodegenerative changes induced by intranigral 6-hydroxydopamine lesions in a mouse model of Parkinson's disease. The European journal of neuroscience. 2010.
Jönsson ME, Ono Y, Björklund A, Thompson LH. Identification of Transplantable Dopamine Neuron Precursors at Different Stages of Midbrain Neurogenesis. Exp Neurol. 2009.
Björklund A, Dunnett SB. Dopamine neuron systems in the brain: an update. Trends Neurosci. 2007;30(5):194-202.
Carlsson T, Carta M, Winkler C, Björklund A, Kirik D. Serotonin neuron transplants exacerbate L-DOPA-induced dyskinesias in a rat model of Parkinson's disease. J Neurosci. 2007;27(30):8011-22.
Carta M, Carlsson T, Kirik D, Björklund A. Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats. Brain. 2007;130(Pt 7):1819-33.
Sørensen A, Thompson L, Kirik D, Björklund A, Lindvall O, Kokaia M. Functional properties and synaptic integration of genetically labelled dopaminergic neurons in intrastriatal grafts. Eur J Neurosci. 2005;21(10):2793-9.
Thompson L, Barraud P, Andersson E, Kirik D, Björklund A. Identification of dopaminergic neurons of nigral and ventral tegmental area subtypes in grafts of fetal ventral mesencephalon based on cell morphology, protein expression, and efferent projections. J Neurosci. 2005;25(27):6467-77.
Ahn YH, Bensadoun JC, Aebischer P, Zurn AD, Seiger A, Björklund A, et al. Increased fiber outgrowth from xeno-transplanted human embryonic dopaminergic neurons with co-implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor. Brain Res Bull. 2005;66(2):135-42.
Piccini P, Pavese N, Hagell P, Reimer J, Björklund A, Oertel WH, et al. Factors affecting the clinical outcome after neural transplantation in Parkinson's disease. Brain. 2005;128(Pt 12):2977-86.
Lindvall O, Björklund A. Cell therapy in Parkinson's disease. NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics. 2004;1(4):382-93.
Lindvall O, Björklund A. Cell replacement therapy: helping the brain to repair itself. NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics. 2004;1(4):379-81.
Björklund A, Dunnett SB, Brundin P, Stoessl JA, Freed CR, Breeze RE, et al. Neural transplantation for the treatment of Parkinson's disease. Lancet neurology. 2003;2(7):437-45.
Winkler C, Kirik D, Björklund A, Cenci AM. L-DOPA-induced dyskinesia in the intrastriatal 6-hydroxydopamine model of parkinson's disease: relation to motor and cellular parameters of nigrostriatal function. Neurobiol Dis. 2002;10(2):165-86.
Hagell P, Piccini P, Björklund A, Brundin P, Rehncrona S, Widner H, et al. Dyskinesias following neural transplantation in Parkinson's disease. Nat Neurosci. 2002;5(7):627-8.
Lindvall O, Brundin P, Widner H, Rehncrona S, Gustavii B, Frackowiak R, et al. In Reply: Fetal Brain Grafts and Parkinson's Disease. Science. 1990;250(4986):1435.

]